Evofem biosciences stock
What's the price of evofem Biosciences'shares? Since then, EVFM shares have fallen and are now trading at USD. Find out which stocks have been most affected by COVID19. When is the next release date for Evofem Biosciences? Evofem Biosciences is expected to publish its next quarterly results on Thursday, March 3, 2022. See Evofem Biosciences' revenue forecast.
What is the upside for evofem Biosciences'stock?
5 brokers have set one-year price targets for Evofem Biosciences stock. Your forecast varies between $ and $. On average, they expect Evofem Biosciences' stock price to hit $10 over the next 12 months. This implies an upside potential of 1% of the current share price.
What does a hold rating on evofem Biosciences (evfm) mean?
The Holding's rating indicates that analysts believe that investors should maintain their existing positions in EVFM, but not buy additional shares or sell existing shares. View analyst ratings for Evofem Biosciences or top rated stocks.
Who is the CEO of evevofem Biosciences?
Evofem Biosciences, Inc. (NASDAQ: EVFM) announced today that CEO Saundra Pelletier will participate in keynotes and face-to-face meetings at the 33rd Annual Piper Sandler Virtual Health Conference, December 29-2, 2021.
Who bought evofem Biosciences Inc (evfm) stock?
CEO of Evofem Biosciences Inc (30-year financing, insider trading), Saundra L. Pelletier (insider trading), purchased 135,000 shares of EVFM on 12/20/2021 at an average price of $per share.
What is the ticker symbol for evofem Biosciences?
Evofem Biosciences is listed on NASDAQ under the symbol EVFM. How to Buy Evofem Biosciences Shares? EVFM shares can be purchased through any online brokerage account.
What are analysts'target prices for evofem Biosciences'stock?
Two brokerage firms have published 12-month target prices for the shares of Evofem Biosciences. Your forecast varies between $ and $. On average, they expect Evofem Biosciences' stock price to hit $10 over the next 12 months. This indicates a possible rise in the current share price.
What is evevofem Biosciences?
Evofem Biosciences, Inc. is a commercial-stage biopharmaceutical company that develops and markets innovative products to address the unmet sexual and reproductive health needs of women.
What is the upside from evofem Biosciences (EVF) stock?
Analysts say shares of Evofem Biosciences are expected to rise based on 12-month price targets. Which Analysts Cover Evofem Biosciences?
What is the price targets for evofem Biosciences?
Evofem Biosciences has a 12 month average price target of $ with a $ high target and a $ low target. Read More Do Wall Street Analysts Think Evofem Biosciences Outperforms Its Competitors?
![:eight_spoked_asterisk:]( ":eight_spoked_asterisk:")
Do analysts like evofem Biosciences (Evo) stock compared to its medical competitors?
Analysts like Evofem Biosciences have fewer shares than other medical companies. The consensus score of Evofem Biosciences is equal to the average consensus score of medical companies in.
![:brown_circle:]( ":brown_circle:")
How much is evofem stock worth?
Currently, EVFM shares can be bought for about $1. How much money does Evofem Biosciences make? Evofem Biosciences has a market capitalization in the millions of dollars and annual sales of $450,000.
Is evofem Biosciences (evfm) stock a good buy?
Based on ratings from 3 analysts over the past year, the consensus rating for the stock is Buy Evofem Biosciences, based on EVFM's current rating of 1 hold and buy 2. The 12-month moving average target price for Evofem Biosciences is $ with a high $ target and a low $ target .
![:brown_circle:]( ":brown_circle:")
Where is evofem Biosciences located?
Evofem Biosciences is headquartered at 12400 HIGH BLUFF DRIVE SUITE 600, SAN DIEGO CA, 92130. How can I contact Evofem Biosciences?
![:diamond_shape_with_a_dot_inside:]( ":diamond_shape_with_a_dot_inside:")
How much of evofem Biosciences'stock is owned by insiders?
Specifically, they bought the company's stock for $76 and sold the company's stock for $76. Only a portion of Evofem Biosciences' stock is owned by insiders.
![:eight_spoked_asterisk:]( ":eight_spoked_asterisk:")
What does evofem Biosciences do?
Sign up to receive the latest news and reviews from Evofem Biosciences and its competitors in the FREE daily MarketBeats newsletter. Evofem Biosciences, Inc. is a commercial biopharmaceutical company that develops and markets innovative products to address the unmet sexual and reproductive health needs of women.
![:eight_spoked_asterisk:]( ":eight_spoked_asterisk:")
What is the price targets for evfm?
The high target price for EVFM is $ and the low target price for EVFM is $. There are currently 3 buy advices for the stock, resulting in a consensus buy advice.
What is evevofem's vaginal pH modulator?
Evofem is using its proprietary vaginal pH modulator to develop product candidates to prevent two common sexually transmitted diseases and reduce recurrent bacterial vaginosis (BV).
![:eight_spoked_asterisk:]( ":eight_spoked_asterisk:")
What is the evo100 Fast Track designation?
The Food and Drug Administration has awarded the EVO100 Fast Track a designation for the prevention of chlamydia and gonorrhea. The Fast Track designation is intended to facilitate the development and accelerate the assessment of new treatments for serious conditions and unmet medical needs.
![:diamond_shape_with_a_dot_inside:]( ":diamond_shape_with_a_dot_inside:")
What does a hold rating on evofem biosciences (evfm) mean &
Based on the ratings provided by two analysts last year, the consensus rating for the stock is Evofem Biosciences Hold, based on EVFM's current rating of 1 sell and 1 buy. The 12-month moving average target price for Evofem Biosciences is $ with a high $ target and a low $ target.
![:brown_circle:]( ":brown_circle:")
What's happening with evofem Biosciences stock?
Shares of Evofem Biosciences (NASDAQ:EVFM) fell at 11:43 AM. ET Friday, after falling as much as earlier in the day. These huge losses came after it was announced that the company's CEO, Soundra Pelletier, had sold 122,500 shares of the company on September 8 for $1 a share.
How do I contact evofem?
You can contact the biotech company at (858) 5501900, email araskopf@, or fax 8448282010.
![:eight_spoked_asterisk:]( ":eight_spoked_asterisk:")
Who is the CEO of evofem?
Saundra Pelletier has been CEO, President and CEO of Evofem Biosciences since February 2015. Ms. Pelletier was responsible for the company's growth and development and led the launch of Evofem (NASDAQ: EVFM) in January 2018.
![:eight_spoked_asterisk:]( ":eight_spoked_asterisk:")
What is evofem Biosciences?
Evofem Biosciences is revolutionizing women's sexual and reproductive health by developing an innovative hormone-free contraceptive and STD prevention product. Evofem's mission is to empower women by providing products that give them the control and flexibility they desire.
![:eight_spoked_asterisk:]( ":eight_spoked_asterisk:")
What is evevofem Biosciences'(EVEV) return on equity?
Evofem Biosciences had a negative net margin of 4 and a negative return on equity of 1 year over year. For the same period last year, the company had earnings per share ($).
![:eight_spoked_asterisk:]( ":eight_spoked_asterisk:")
What did evevofem Biosciences (evfm) announce?
Evofem Biosciences, Inc. (NASDAQ: EVFM) announced today that it has successfully extended its combined schedule of net sale and securities purchase agreement from April 2020 to June 30, 2023.
